The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer therapy with few efficacious treatments.
Conclusion and relevance: Among patients with CIPN, PBM produced significant reduction in neuropathy symptoms.
“Therapy lasers have been an exciting addition to the health care treatment arsenal. The development of Class IV therapy lasers represents the next generation of light therapy. By maximizing the primary effects, Class IV therapy lasers are able to induce extremely rapid clinical responses. Progressive health care providers wanting to offer the latest technology to their clientele should investigate Class IV therapy lasers.”
— Dr. Julian Vickers (deceased)
Note from Dr. Phil
Dr. Julian was taken away from us too soon. He passed away in 2009, shortly after he and I authored this article on Class 4 Laser Therapy. He was a good man. I think of him often, and I look forward to seeing him again on the other side.